Clinical use of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for the diagnosis of gastro-esophageal reflux disease
- PMID: 35768671
- PMCID: PMC9436885
- DOI: 10.1007/s10388-022-00933-6
Clinical use of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for the diagnosis of gastro-esophageal reflux disease
Abstract
The clinical diagnosis of gastro-esophageal reflux disease (GERD) is based on the presence of typical esophageal troublesome symptoms. In clinical practice, heartburn relief following a proton pump inhibitor (PPI) trial or endoscopy can confirm a diagnosis of GERD. In cases of diagnostic uncertainty or before anti-reflux interventions, combined impedance-pH monitoring (MII-pH) provides a comprehensive assessment of both physical and chemical properties of the refluxate, allowing to achieve a conclusive diagnosis of GERD. Recently, the Lyon Consensus proposed the use of mean nocturnal baseline impedance (MNBI) and post-reflux swallow-induced peristaltic wave index (PSPW-I) as novel MII-pH metrics to support the diagnosis of GERD. The calculation of MNBI and PSPW-I currently needs to be performed manually, but artificial intelligence systems for the automated analysis of MII-pH tracings are being developed. Several studies demonstrated the increased diagnostic yield MNBI and PSPW-I for the categorization of patients with GERD at both on- and off-PPI MII-pH monitoring. Accordingly, we performed a narrative review on the clinical use and diagnostic yield of MNBI and PSPW-I when the diagnosis of GERD is uncertain. Based on currently available evidence, we strongly support the evaluation of PSPW-I and MNBI as part of the standard assessment of MII-pH tracings for the evaluation of GERD, especially in patients with endoscopy-negative heartburn.
Keywords: Diagnosis; GERD; MNBI; PSPW index; Reflux disease.
© 2022. The Author(s).
Conflict of interest statement
Pierfrancesco Visaggi: None; Lucia Mariani: None; Federica Baiano Svizzero: None; Luca Tarducci: None; Andrea Sostilio: None; Marzio Frazzoni: None; Salvatore Tolone: None; Roberto Penagini: received Lecture Fee: Alfasigma, Reckitt Benckiser, Sofar, Leonardo Frazzoni: None, Linda Ceccarelli: None; Vincenzo Savarino: received lecture fees from Reckitt Benkiser, Takeda, Grunenthal, Teofarma, Alfasigma; Massimo Bellini: None, Prakash C Gyawali: None, Edoardo V. Savarino: received lecture fees from Abbvie, Alfasigma, Amgen, Aurora Pharma, Bristol-Myers Squibb, EG Stada Group, Fresenius Kabi, Grifols, Janssen, Johnson&Johnson, Innovamedica, Malesci, Medtronic, Merck & Co, Reckitt Benckiser, Sandoz, Shire, SILA, Sofar, Takeda, Unifarco, Nicola de Bortoli: received lecture fees from Malesci and Reckitt Benckiser.
Figures


Similar articles
-
Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus.Aliment Pharmacol Ther. 2021 Aug;54(4):412-418. doi: 10.1111/apt.16481. Epub 2021 Jun 28. Aliment Pharmacol Ther. 2021. PMID: 34181753 Free PMC article.
-
Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives.Dig Dis Sci. 2017 Aug;62(8):1881-1889. doi: 10.1007/s10620-017-4625-8. Epub 2017 May 26. Dig Dis Sci. 2017. PMID: 28550489 Review.
-
The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring.Neurogastroenterol Motil. 2017 Mar;29(3). doi: 10.1111/nmo.12947. Epub 2016 Sep 12. Neurogastroenterol Motil. 2017. PMID: 27620303
-
Post-reflux swallow-induced peristaltic wave index and mean nocturnal baseline impedance predict PPI response in GERD patients with extra esophageal symptoms.Dig Liver Dis. 2020 Feb;52(2):173-177. doi: 10.1016/j.dld.2019.09.011. Epub 2019 Oct 14. Dig Liver Dis. 2020. PMID: 31623954
-
The Role of Mean Nocturnal Baseline Impedance and Post-Reflux Swallow-Induced Peristaltic Wave Index in the Diagnosis and Treatment of Gastroesophageal Reflux Disease.Dig Dis. 2023;41(1):1-9. doi: 10.1159/000527867. Epub 2022 Nov 7. Dig Dis. 2023. PMID: 36349754 Review.
Cited by
-
Pathophysiology of Gastroesophageal Reflux Disease.Digestion. 2025 Jun 25:1-17. doi: 10.1159/000547023. Online ahead of print. Digestion. 2025. PMID: 40562014 Free PMC article. Review.
-
Hyaluronic acid and chondroitin sulfate-based medical devices: formulations, esophageal mucosal protection, and their place in the management of GERD.Therap Adv Gastroenterol. 2025 Jun 11;18:17562848251337822. doi: 10.1177/17562848251337822. eCollection 2025. Therap Adv Gastroenterol. 2025. PMID: 40520453 Free PMC article. Review.
-
Do all patients need pH impedance testing to document gastroesophageal reflux in Indian setting?Indian J Gastroenterol. 2024 Jun;43(3):691-692. doi: 10.1007/s12664-023-01439-4. Indian J Gastroenterol. 2024. PMID: 37584886 No abstract available.
-
Extended Wireless pH Monitoring Significantly Increases Gastroesophageal Reflux Disease Diagnoses in Patients With a Normal pH Impedance Study.J Neurogastroenterol Motil. 2023 Jul 30;29(3):335-342. doi: 10.5056/jnm22130. J Neurogastroenterol Motil. 2023. PMID: 37417260 Free PMC article.
-
Utility of the Post-Reflux Swallow-Induced Peristaltic Wave Index and Mean Nocturnal Baseline Impedance for the Diagnosis of Gastroesophageal Reflux Disease Phenotypes in Children.Children (Basel). 2024 Jun 26;11(7):773. doi: 10.3390/children11070773. Children (Basel). 2024. PMID: 39062223 Free PMC article.
References
-
- Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–1920. - PubMed
-
- Chiocca JC, Olmos JA, Salis GB, et al. Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: a nationwide population-based study. Aliment Pharmacol Ther. 2005;22:331–342. - PubMed
-
- Cho YS, Choi MG, Jeong JJ, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si. Korea Am J Gastroenterol. 2005;100:747–753. - PubMed
-
- Locke GR, 3rd, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448–1456. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical